Loading ...

Paclitaxel-encapsulating TLTYTWS peptide-modified poly(ethylene glycol)-poly(lactic acid) nanoparticles

Based on

1 Articles
2017 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

Me-PEG-PLA/Mal-PEG-PLA mixture

Type Complex Compound
Formula
Role carriers
2

Paclitaxel

Plaxicel Abraxane Paxene Taxol PCL PAC PTX PX
Type Single Compound
Formula C47H51NO14
Role loaded material
3

CTLTYTWS

Type Biomolecule
Formula
Role layer

Properties

General physical and chemical properties

Property Value Nanomaterial Variant Source
drug release dependent on liquid medium

More information/entries available to subscribers only.

Or, view sample content

Applications

Area Application Nanomaterial Variant Source
drug delivery

More information/entries available to subscribers only.

Or, view sample content

Characterization

Method Nanomaterial Variant Source
atomic force microscopy

More information/entries available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Nanomaterial Variant Source
male Sprague-Dawley rat

More information/entries available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Chemical synthesis
Source:
Product

Paclitaxel-encapsulating TLTYTWS peptide-modified poly(ethylene glycol)-poly(lactic acid) nanoparticles

Diameter: 72.3 - 104.3 nm

Hydrodynamic diameter: 123.9 - 246.7 nm

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial